ATORVASTATIN CALCIUM
- Product NDC
- 50090-5051
- 11-digit product format
- 500905051
- Labeler code
- 50090
- Product ID
- 50090-5051_d5ece8d8-575d-4bed-9cef-5a225880050b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ATORVASTATIN CALCIUM
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA205945
- Marketing category
- ANDA
- Marketing start
- 2020-01-01
- Marketing end
- 0000-00-00
- Substance
- ATORVASTATIN CALCIUM TRIHYDRATE
- Active strength
- 80 mg/1
- Pharmacologic classes
- HMG-CoA Reductase Inhibitor [EPC],Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-5051-0 | ATORVASTATIN CALCIUM | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | | 3 |
| 50090-5051-1 | ATORVASTATIN CALCIUM | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-5051 | ATORVASTATIN CALCIUM (ATORVASTATIN CALCIUM) TABLET, FILM COATED [A-S MEDICATION SOLUTIONS] | 3 | Legacy NDC, 2 package rows | 20210417_5e3d1d0c-0f1d-4aa0-846c-e2f132a959ac.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50090-5051-0 | 50090505100 | 30 TABLET, FILM COATED in 1 BOTTLE (50090-5051-0) | 2020-05-18 | 0000-00-00 | No | No | Current |
| 50090-5051-1 | 50090505101 | 90 TABLET, FILM COATED in 1 BOTTLE (50090-5051-1) | 2020-05-18 | 0000-00-00 | No | No | Current |